| Old Articles: <Older 34241-34250 Newer> |
|---|
 |
The Motley Fool
January 26, 2009
Brian Orelli |
Deja Vu All Over Again There's hardly anything to like about Pfizer's deal to buy Wyeth. This is what got Pfizer into its problem in the first place.   |
The Motley Fool
January 26, 2009
Alyce Lomax |
McDonald's Still a Winner Investors should still be hungry for McDonald's in these tough economic times. |
The Motley Fool
January 26, 2009
Rich Smith |
Harley-Davidson Running on Fumes Harley-Davidson CEO Jim Ziemer announced a series of seatbelt-tightening measures. |
The Motley Fool
January 26, 2009
John Rosevear |
Now It's a Real Crisis There are more hard times -- and more opportunities -- coming soon. |
The Motley Fool
January 26, 2009
David Lee Smith |
Schlumberger: Set for Success? The oil-services giant's quarter was predictably bland, but shareholders still smile. |
The Motley Fool
January 26, 2009
Brian Orelli |
Have Drugs, Will Travel After buying Bristol-Myers Squibb's businesses in Egypt and Pakistan, GlaxoSmithKline is now off to Africa. |
The Motley Fool
January 26, 2009
Brian Orelli |
Which One of These Is Not Like the Other? Bristol-Myers and Eli Lilly run into some comparability issues. |
The Motley Fool
January 26, 2009
Anders Bylund |
Foolish Forecast: Yahoo!'s Last Yodel? In advance of Yahoo!'s earnings report, let's take a look at some of their peers and competitors. |
The Motley Fool
January 26, 2009
Tim Beyers |
A New Plan Needed Zune Sales don't drop by this much unless there's something seriously wrong. Microsoft's Zune player is dying. Fast. |
The Motley Fool
January 26, 2009
Rick Aristotle Munarriz |
Beware of Cash-Rich Companies As reasonable investors, we're trained to spot companies that have top-heavy income statements. However, cash-rich companies may break your heart. Read on for more. |
| <Older 34241-34250 Newer> Return to current articles. |
